(Reuters) - Johnson & Johnson is negotiating a potential $2 billion settlement with patients who received its recalled artificial hip implant, Bloomberg News reported on Friday, citing five people ...

DePuy Synthes has entered into an exclusive agreement with JointPoint Inc. to co-market a proprietary software platform that aims to help surgeons perform hip replacement surgeries. JointPoint's ...

The High Court of England and Wales ruled DePuy’s Ultamet Metal-on-Metal Articulation hip replacement device was not defective, ending a months-long trial involving more than 300 patients, Medical ...

A Texas judge Tuesday limited damages against Johnson & Johnson’s DePuy unit in a lawsuit involving allegedly defective metal-on-metal Pinnacle hip implants, which were pulled from the market in 2013, ...

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with ...

CHICAGO (Reuters) - Johnson & Johnson, whose consumer unit has been plagued by massive recalls over the past year, said on Thursday its orthopedic unit was voluntarily recalling two hip replacement ...

A new type of hip replacement implant reduces the risk of joint dislocation after surgery by 70 per cent. This is the finding ...